Millennium Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Millennium Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-157,606	Closed	-$2.66M	–	6870
2023 Q2	$2.66M	Buy	+157,606	New	+$2.07M	﹤0.01%	3230
2022 Q2	–	Sell	-12,126	Closed	-$57K	–	7745
2022 Q1	$57K	Sell	12,126 -4,530	-27%	-$23.7K	﹤0.01%	6361
2021 Q4	$82K	Sell	16,656 -67,895	-80%	-$335K	﹤0.01%	6330
2021 Q3	$653K	Sell	84,551 -10,663	-11%	-$91.4K	﹤0.01%	5094
2021 Q2	$1.11M	Buy	+95,214	New	+$1.45M	﹤0.01%	4570

Other funds holding VECT

Regency Capital Management Honolulu, Hawaii $251M AUM 32.13% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Millennium Management's VECT Position: Q3 2023 in Review

Millennium Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 157,606 shares — an estimated $2.66M sold.

Millennium Management first reported a position in VECT in Q2 2021 and held it in 5 quarters. The position peaked at $2.66M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Millennium Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 157,606 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $2.66M.
Millennium Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 5 quarters.
Millennium Management's VectivBio Holding AG Ordinary Shares position peaked at $2.66M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.